(HIMS) Hims Hers Health - Ratings and Ratios

Hims & Hers Health, Inc. is a telehealth company that connects consumers with licensed healthcare professionals across the US, UK, and internationally, offering a range of curated health and wellness products and services. The companys platform provides customers with access to prescription medication, ongoing care, and over-the-counter products, including cosmetics and supplements, focusing on general wellness, sexual health, skincare, and hair care.

The companys product offerings are diverse, with curated non-prescription products in categories such as wellness, skincare, sexual health, and hair care. For instance, in the wellness category, they offer melatonin and biotin, while in skincare, they offer moisturizers, creams, and sunscreen. This diverse product range allows the company to cater to a wide range of customer needs, setting it apart from more specialized telehealth providers.

From a technical analysis perspective, the stocks current price is $56.33, with support levels at $52.7, $45.0, and $36.2, and resistance levels at $56.6 and $64.8. Given the current SMA20 at $56.76 and SMA50 at $41.89, the stock is showing a bullish trend, with the short-term moving average above the long-term moving average. The ATR of 5.33 (9.46%) indicates moderate volatility.

Using the available technical and fundamental data, a forecast can be made. With a Market Cap of $11.728B and a P/E ratio of 77.06, the company is valued at a premium. However, the RoE of 35.97% indicates strong profitability. Considering the 52W High of $68.74 and 52W Low of $13.65, the stock has shown significant growth potential. If the stock can break through the resistance level at $64.8, it may be poised for further growth, potentially reaching new highs. Conversely, if it falls below the support level at $52.7, it may experience a correction.

Based on the analysis, a potential trading strategy could be to buy the stock at the current price, with a stop-loss at $52.7, and a take-profit at $64.8. However, this strategy is subject to change based on future market developments and the companys performance.